PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample

Diabetes, Obesity & Metabolism
A M WolfJ-P Despres

Abstract

To summarize baseline characteristics, health conditions, resource utilization and resource cost for the US population for the 90-day period preceding enrolment, stratified by body mass index (BMI) and the presence of abdominal obesity (AO). PROCEED (Prospective Obesity Cohort of Economic Evaluation and Determinants) is a multinational, prospective cohort of control (BMI 20-24.0 kg/m(2)), overweight (BMI 25-29.9 kg/m(2)) and obese (BMI >or= 30 kg/m(2)) subjects with AO and without AO [non-abdominal obesity (NAO)], defined by waist circumference (WC) >102 and 88 cm for males and females, respectively. Subjects were recruited from an Internet consumer panel. Outcomes were self-reported online. Self-reported anthropometric data were validated. Prevalence of conditions and utilization is presented by BMI class and AO within BMI class. Differences in prevalence and means were evaluated. A total of 1067 overweight [n = 474 (NAO: n = 254 and AO: n = 220)] and obese [n = 493 (NAO: n = 39 and AO: n = 454)] subjects and 100 controls were recruited. Self-reported weight (r = 0.92) and WC (r = 0.87) were correlated with measured assessments. Prevalence of symptoms was significantly higher in groups with higher BMI, as were hypertension (p ...Continue Reading

References

Sep 1, 1990·American Journal of Epidemiology·G A ColditzF E Speizer
Jan 16, 1987·JAMA : the Journal of the American Medical Association·J E MansonW C Willett
Feb 8, 1995·JAMA : the Journal of the American Medical Association·W C WillettC H Hennekens
Mar 7, 1996·The New England Journal of Medicine·R M Williams
Mar 1, 1996·The American Journal of Clinical Nutrition·R Ballard-Barbash, C A Swanson
Jan 1, 1998·The New England Journal of Medicine·J StevensJ L Wood
Mar 21, 1998·Archives of Internal Medicine·C P QuesenberryA Jacobson
Apr 17, 1998·Obesity Research·A M Wolf, G A Colditz
May 6, 1998·Obesity Research·A M Wolf
Oct 20, 1998·Journal of Occupational and Environmental Medicine·W N BurtonD W Edington
Dec 10, 1998·JAMA : the Journal of the American Medical Association·K M RexrodeJ E Manson
Dec 8, 1997·American Journal of Health Promotion : AJHP·L A Tucker, G M Friedman
May 27, 1999·American Journal of Health Promotion : AJHP·D ThompsonG Oster
Jul 18, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S KuriyamaS Hisamichi
Jan 17, 2003·Obesity Research·Wei ShenSteven B Heymsfield
Apr 30, 2003·Diabetes·Charles M AlexanderUNKNOWN National Cholesterol Education Program (NCEP)
Oct 27, 2004·Archives of Internal Medicine·Marsha A RaebelFrances A Lanty
Mar 10, 2005·The American Journal of Clinical Nutrition·Youfa WangFrank B Hu

❮ Previous
Next ❯

Citations

Dec 3, 2013·Translational Behavioral Medicine·Donna M ZulmanCaroline R Richardson
Sep 14, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C HolzapfelH Hauner
Mar 10, 2009·Diabetes/metabolism Research and Reviews
Jan 12, 2010·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A G TsaiH A Glick
May 9, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M BierlK Rtveladze
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David D Kim, Anirban Basu
Dec 21, 2017·PloS One·Jorge Federico ElgartUNKNOWN QUALIDIAB Net study group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.